本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Trevi Therapeutics Inc.

10.53
+0.03000.29%
盘后10.590.0600+0.57%17:12 EDT
成交量:150.37万
成交额:1,602.05万
市值:12.82亿
市盈率:-25.34
高:10.90
开:10.48
低:10.37
收:10.50
52周最高:11.11
52周最低:2.36
股本:1.22亿
流通股本:9,063.42万
量比:1.21
换手率:1.66%
股息:- -
股息率:- -
每股收益(TTM):-0.4155
每股收益(LYR):-0.4698
净资产收益率:-35.74%
总资产收益率:-22.83%
市净率:6.46
市盈率(LYR):-22.41

数据加载中...

2024/05/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/21

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/05/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/07

重要事件披露

Form 8-K - Current report
2024/04/25

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/03/20

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/20

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/20

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/12

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/11/10

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/10

重要事件披露

Form 8-K - Current report
2023/09/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/15

SEC问询函

Form CORRESP - Correspondence
2023/08/11

重要事件披露

Form 8-K - Current report
2023/08/10

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/06/29

重要事件披露

Form 8-K - Current report
2023/06/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities